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Abstract 
Purpose: To investigate the solubilization of poorly water-soluble non-steroidal anti-inflammatory drugs 
(NSAIDs) in N-benzyl-N,O-succinyl chitosan (BSCS) polymeric micelles 
Methods: BSCS was synthesized by reductive amination and succinylation, respectively. NSAIDs; 
meloxicam (MX), piroxicam (PRX), ketoprofen (KP) and indomethacin (IND) were entrapped in the 
hydrophobic inner cores by evaporation method. The effects of drug structure on loading efficiency, 
particle size and surface charge of micelles were investigated. 
Results: The critical micelle concentration of BSCS micelles was 0.0385 mg/mL and cytotoxicity on 
Caco-2 cells depends on the polymer concentration (IC50 = 3.23 ± 0.08 mg/mL). BSCS micelles were 
able to entrap MX, PRX, KP and IND and also improve the solubility of drugs. Drug loading efficiency 
was highly dependent on the drug molecules. The drug loading capacity of these BSCS micelles was in 
the following rank order: KP (282.9 µg/mg) > PRX (200.8 µg/mg) > MX (73.7 µg/mg) > IND (41.2 
µg/mg). The highest loading efficiency was observed in KP-loaded BSCS micelles due to the attractive 
force between phenyl groups of KP and benzyl groups of the polymer. Particle size and surface charge 
were in the range of 312 - 433 nm and -38 to -41 mV, respectively. 
Conclusion: BSCS copolymer presents desirable attributes for enhancing the solubility of hydrophobic 
drugs. Moreover, BSCS polymeric micelles might be beneficial carrier in a drug delivery system. 
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One-third of the drugs identified are poorly water 
soluble, which is one of the important hindrances 
for successful development and the therapy of 
the orally administered drug effective [1,2]. 
Based on the Biopharmaceutics Classification 
System (BCS), these drugs could be classified 
as class II and class IV. The rate and extent of 
absorption as well as the bioavailability of class II 
and IV drugs are ultimately depends on solubility 
of the drugs[3].The most commonly used 
techniques for increasing the drug solubility are 
solid dispersions, cosolvency, pH adjustment, 
micellization, etc [4]. 
 
The core-shell polymeric micelles is an 
alternative technique to dissolve hydrophobic 
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drugs. Drug-incorporated polymeric micelles can 
be formulated from amphiphilic copolymer with 
entrapped drug in the hydrophobic inner core 
and hydrophilic segment surrounding aqueous 
medium to stabilize the micelles. There has been 
great importance in the use of polymeric micelles 
as drug carriers [5]. The successful of 
hydrophobic drugs loaded into polymeric micelles 
can solubilize 10-5000 fold in aqueous solutions 
[6]. 
 
Chitosan (CS) and its derivatives are currently 
receiving attention in medical and 
pharmaceutical applications because of 
biodegradable, biocompatible and less expensive 
[7,8]. Generally, CS dissolve in aqueous acidic 
media. However, it cannot formulate polymeric 
micelles in water. CS derivatives have been 
modified in order to improve the solubility and 
employed in various formulations for the delivery 
of hydrophobic drugs such as microspheres, 
nanoparticles [9-11]. In our previous work, pH 
sensitive polymers from chitosan-based were 
successfully synthesized, and applied in oral 
curcumin [12] and oral meloxicam (MX) 
deliveries [13]. The evaporation method 
presented higher MX incorporated into NSCS 
polymeric micelles than other entrapment 
methods. In addition, the cytotoxicity of BSCS 
micelles had low on Caco-2 cells [14]. Therefore, 
in this experiment, BSCS was synthesized and 
used to entrap four NSAIDs with poorly water 
solubility, including MX, piroxicam (PRX), 
ketoprofen (KP) and indomethacin (IND) as 
model drugs in the hydrophobic core of the 
polymeric micelles by evaporation method to 
investigate the effect of drug structure on the 






Chitosan (CS) (DDA = 96±2 % as investigated 
using NMR) was obtained from OilZac 
Technologies (Bangkok, Thailand) [12,13]. 
Benzaldehyde, sodium borohydride (NaBH4), 
succinic anhydride, MX, PRX, KP and IND were 
procured from Sigma Aldrich (St. Louis, USA). 
Dialysis tube (MWCO = 3500 Da) was obtained 
from Cellu Sep T1 (Segiun, USA).The Caco-2 
cell line was obtained from the American Type 
Culture Collection (Rockville, USA). All other 
substances were of analytical grade. 
 
Synthesis of amphiphilic derivatives of 
chitosan 
 
The modified chitosan derivative, N-benzyl-N,O- 
succinyl chitosan (BSCS), was produced using 
reductive benzylation and succinylation, 
respectively, for grafting hydrophobic and 
hydrophilic functional groups onto the CS 
structure as described in the literature [12,14]. 
Firstly, Benzaldehyde (2.0 meq/GlcN) was added 
in dissolving CS solution. The mixture solution 
was then stirred for 24 h at room temperature, 
and adjusted pH to 5 by 1 M sodium hydroxide. 
The reaction mixture was converted by sodium 
borohydride (52.9 mmol) to obtain the N-benzyl 
chitosan (BCS). Next step, BCS was dispersed in 
N,N­dimethylformamide (DMF). Succinic 
anhydride (5.0 meq/GlcN) was added in BCS 
solution via N,O-succinylation reaction under 
nitrogen atmosphere for 24 h at 100°C. After 
cooling process, the reaction mixture was filtered 
and dialyzed against deionized water to obtain 
the clear solution. Finally, the obtained 
amphiphilic CS derivative was dried to collect by 
freeze dehydration. 
 
Characterization amphiphilic derivatives of 
chitosan 
 
The CS or BSCS sample was measured 1H NMR 
spectrometer (Bruker, Switzerland). Tetra-
methylsilane (TMS) was exploited as an internal 
standard [13]. Fourier transform infrared (FTIR) 
was carried out using a Nicolet 6700 
spectrometer (Thermo Company, USA) at 25 °C. 
The molecular weight of amphiphilic CS 
derivative was evaluated via gel permeation 
chromatography (GPC) analysis utilizing a 
waters 600 E series instrument equipped with an 
ultrahydrogel column, and a water 2410 
refractive index (RI) detector [12]. 
 
Fluorescence spectroscopy was used to 
investigate the critical micelle concentration 
(CMC) of BSCS using hydrophobic pyrene as a 
fluorescent probe [15]. An aliquot (10 µL) of 1 
mM pyrene solution in acetone was placed in the 
small glass bottles containing a concentration 
sequence of aqueous copolymer media from 0.5 
× 10−3 to 3.9 × 10−3mg/mL (4 mL). The amount 
was adjusted to give a pyrene concentration in 
the final solution of each sample at 2.5×10−6 M. 
The mixture solutions were sonicated for 15 min, 
heated at 50°C for 2 h to equilibrate the pyrene 
and the micelles, and then stored to cool 
overnight in dark at ambient temperature. 
Fluorescence excitation was set at 335 nm, and 
the emission band was observed from 350 to 500 
nm. After measuring, the intensity ratio of I373/I382 
was plotted as a function of logarithm the 
concentration of polymer and the CMC was 
calculated. 
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In vitro cytotoxicity assay 
 
The in vitro cytotoxicity of blank BSCS against 
Caco-2 cells was investigated by an MTT assay 
[16]. Overall, The Caco-2 cells were incubated in 
DMEM solution at pH 7.4 and were kept at 37 °C 
in 5 % CO2 atmosphere. The cells were seeded 
into each well of 96-well plates with a density of 
10,000 cells/well and pre-incubated for 24 h to 
allow cell attachment.  
 
Thereafter, blank micelles in 100 µL of DMEM 
were added to each well of the Caco-2 cells. 
After 24 h, the medium was removed and the 
wells were washed. Then, the wells were filled 
with 200 µL of new medium, and incubated the 
cells were with MTT solution (1 mg/mL) for 
additional 4 h. After removal of the medium, 100 
µL of DMSO was added to dissolve the formed 
formazan crystals. The cell viability was 
calculated based on the absorbance 
measurements at 550 nm using a microplate 
reader (Packard BioScience, USA). The viability 
of non-treated control cells was arbitrarily defined 
as 100 %. 
 
Preparation of drug-loaded polymeric 
micelles 
 
A mixed-solvent evaporation method was 
selected to prepare polymeric micelles as 
previously described [13]. Briefly, 5 mg of BSCS 
and drugs (MX, PRX, KP, IND) (at 40 % 
concentration of the drug to polymer) were 
dissolved in DMF in a small glass container. After 
dissolving, small amount of acetone was added 
and stirred at ambient temperature. The solvent 
of the mixed solution was then completely 
evaporated under nitrogen gas flow. Then, 
deionized water (3 mL) was added, and the 
mixture was sonicated for 20 min at 80 °C using 
a probe sonicator (model CV 244, USA). The 
micellar solution was then centrifuged at 1000 
rpm for 2 min, filtered through a 0.45-µm 
membrane filter to remove insoluble drug. 
 
Determination of entrapment efficiency 
 
To measure drug loading efficiency and loading 
capacity, 0.1 mL of the drug-incorporated 
polymeric micelles were mixed with 0.9 mL of a 
mixture solvent of dimethyl sulfoxide (DMSO) : 
H2O (9:1). The drug content incorporated into 
BSCS micelles was measured using HPLC 
(Agilent technologies, USA). The entrapment 
efficiency (EE) and loading capacity (LC) of the 
drugs were calculated according to Eqs.1 and 2, 
respectively. All samples were analyzed in 
triplicate. 
 
  ……………………..  (1) 
 
where C1 is the amount of drug loaded into the 
polymeric micelles, and C2 is the initial amount of 
drug used for preparation.  
 
…………………..  (2) 
 
where L1 is the amount of drug incorporated into 
the polymeric micelles, and L2 is the amount of 
BSCS used for the preparation. 
 
High performance liquid chromatography 
(HPLC) conditions 
 
The amount of the drugs encapsulated into the 
polymeric micelles was investigated using by 
HPLC with a Luna® 5 µm C18 (2) column 
according to a calibration curve generated from a 
series of standard solutions ranging from 5 to 50 
µg/mL. The injection volume was 20 µL. The 
mobile phase used for each drug was described 
in Table 1 [17-19]. 
 
Table 1: HPLC experimental conditions used to 
quantify NSAIDs concentrations [17-19] 
 


























Polymeric micelle size and surface charge 
measurement 
 
The mean particle diameter and surface charge 
of the BSCS polymeric micelles with and without 
drugs were assessed using Zetasizer Nano ZS 
(Malvern, UK) in triplicate at 25°C. The diluted 
micellar solution was passed through a 0.45-µm 
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All data are presented as mean ± standard 
deviation (SD, n = 3). A one-way analysis of 
variance (ANOVA) was used to test the statistical 
significance between means using SPSS 17.0 
statistical software program. A p-value of 0.05 or 




Characteristics of BSCS 
 
Grafted copolymer, BSCS, was successfully 
synthesized onto a CS backbone via reductive 
benzylation and succinylation, respectively 
(Figure 1). Overall, the N-benzylation of CS 
occurred through the corresponding Schiff base 
intermediate, then the N,O-succinylation of BCS 
was performed by reacting with succinic 
anhydride in DMF at 100 °C. 
 
BSCS was characterized using 1H-NMR 
spectroscopy, FTIR and GPC. The 1H-NMR 
spectrum of BSCS exhibited proton signal of the 
benzyl groups at δ 7.32 ppm and the methylene 
protons of the succinyl moiety at δ 2.45 ppm, as 
shown in Figure 2 (a). FTIR spectrum of BCS, 
the result revealed that the features of additional 
absorption bands at 1600, 1494, 743 and 695 
cm-1, compared with spectrum of CS. These 
bands were assigned to C=C stretching and C—
H deformation (out of plane), respectively, arising 
from the benzyl groups [20]. The BSCS spectrum 
exhibited a characteristic band at 1715 cm-1 that 
corresponds to C=O stretching of the succinic 
acid moiety (Figure 2 (b)). The number average 
molecular weight (Mn) of CS by GPC analysis 
was 7633 g/mol. After modification, the Mn of 
BCS and BSCS was increased from 7633 to 
10,552 and 15,628 g/mol, respectively. 
Moreover, the degree of substitution (DS) of 
copolymer was investigated using elemental 
analysis. The DS of the N-benzyl groups (DSB) 
and N,O-succinyl groups (DSS) was computed 
based on the C/N molar ratio achieved from 
elemental analysis according to Eqs 3 and 4, 
respectively [14]. 
 
 …. (3) 
 
 … (4) 
 
DSB was calculated to be 0.69 (approximately 
32.4 repeating units) while the DSS was 1.08 
(approximately 50.7 repeating units) [12,14]. 
 
Self-assembly micelle formation of the BSCS 
copolymer occurs when the concentration is 
above the CMC, which determined by plotting the 
intensity ratio I1/I3 of pyrene versus 




Figure 1: Schematic illustration of the synthesis of N-benzyl-N,O-succinyl chitosan (BSCS) graft copolymer 
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Figure 2: 1H NMR spectra of CS and BSCS (a) and ATR-FTIR of CS, BCS and BSCS (b) 
 
In vitro cytotoxicity 
 
The cytotoxicity of BSCS micelles was 
determined against Caco-2 cells. Figure 3 shows 
the viability of Caco-2 cells after treatment with 
various the concentration (0.01–5 mg/mL) of the 
modified polymer. The IC50 value was calculated 
to be 3.23 ± 0.08 mg/mL. 
 
Drug-loaded polymeric micelles 
 
In this study, four model NSAIDs drugs (MX, 
PRX, IND and KP) with poor aqueous solubility, 
presented the physicochemical properties in 
Table 2 [21,22], were selected to load into BSCS 
polymeric micelles.  The EE (a) and LC (b) of all 
NSAIDs loaded into BSCS polymeric micelles 
are shown in Figure 4. 
 
Polymeric micelle size and surface charge 
 
The particle sizes, size distribution and surface 
charge of blank and four NSAIDs drugs loaded 




Figure 3: Cell viability in Caco-2 cells at varying concentrations of polymeric micelles (n=5; *p < 0.05) 
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Table 2: Physicochemical properties of the drugs [21,22] 
 




351.41 1.09,4.18 0.20a 
Piroxicam (PRX) 
 
331.35 1.86,5.46 0.48a 
Ketoprofen (KP) 
 
254.38 4.4 24.59a 
Indomethacin (IND) 
 
357.79 4.5 0.04b 
a Solubility at pH 6; b Solubility at pH 5.7 
 
 
Figure 4: Entrapment efficiency (a) and loading capacity (b) of NSAIDs drugs (MX, PRX, KP and IND). Each 
value represents mean ± SD (n = 3) 
 
Table 3: Particle size with polydispersity index (PDI) and surface charge of polymeric micelles with and without 
drugs. Each value represents mean ± SD (n = 3) 
 
Polymeric micelles (PMs) Particle size (nm) PDI Zeta potential (mV) 
Blank-PMs 226.63±9.57 0.304 -39.60±1.91 
MX -loaded PMs 312.63±11.75 0.386 -40.67±0.47 
PRX-loaded PMs 402.70±24.81 0.420 -41.53±2.94 
KP-loaded PMs 349.23±7.89 0.430 -38.13±1.92 
IND-loaded PMs 433.53±2.43 0.280 -39.13±0.75 
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The results presented indicate the successful 
synthesis of amphiphilic copolymer via reductive 
amination and succinylation, respectively, onto 
the CS backbone. The copolymer was confirmed 
by 1H NMR spectroscopy, FTIR, GPC and 
elemental analysis. These results revealed the 
successful functionalization of N-benzyl groups 
or N,O-succinyl groups onto the CS backbone. 
The formation polymeric micelles in aqueous 
solution occur when the concentration of the 
copolymer increases above CMC. The CMC of 
BSCS polymeric micelles was very low. This 
value indicates the polymeric micelles are stable 
of structure. The major requirements for drug 
delivery to the body are the polymers used for 
micelle preparation should be non-toxic. Here, 
the cytotoxicity of BSCS micelles was 
determined by quantitative evaluation of cell 
viability using Caco-2 cells. As reported the 
BSCS copolymer micelles had low cytotoxicity 
and would be safe in vivo. 
 
One important problem in drug delivery is the 
deficient solubility of drugs. Polymeric micelles 
are one of the most promising carriers for drug 
delivery and have improved the solubility of 
poorly water soluble drugs by entrap the drug 
into hydrophobic core. Generally, the solubility of 
drugs depends on particle size, the nature and 
composition of the solvent medium, temperature, 
physical form of solid, nature of solute, etc [23]. 
In Table 2, MX and PRX are classified of enolic 
acid derivatives. They have two acid-base 
dissociation constants pKa (1.09, 4.18 for MX and 
1.86, 5.46 for PRX). The isoelectric points (pI), 
which were computed from (pKa1 + pKa2)/2 of MX 
and PRX, are 2.63 and 3.66, respectively. The pI 
is defined as the pH at which the drugs have no 
net charge. When the pH < pI, drugs display a 
positive charge or become a cationic, but when 
pH > pI, drugs turn into a negative charge or 
become an anionic. KP and IND belong to 
propionic acid derivatives with pKa ≈ 4.4 and 
acetic acid derivatives with pKa ≈ 4.5, 
respectively. Both of them are negatively 
charged or anionic at pH > pKa [22]. Thus, the 
solubility of NSAIDs (MX, PRX, KP and IND) 
increased with the increase in pH because of 
ionization of the drugs. However, these drugs 
present low solubility in aqueous solution (Table 
2). The improvement in EE of the four model 
drugs through BSCS polymeric micelles can be 
ranked as KP (70.6 %) > PRX (50.2 %) > MX 
(18.3 %) > IND (10.3 %) (Figure 4a). In addition, 
the drug LC of these BSCS micelles for the four 
model drugs was in the similar rank order; KP 
(282.9 µg/mg) > PRX (200.8 µg/mg) > MX (73.7 
µg/mg) > IND (41.2 µg/mg).  
These high contents indicate successful 
encapsulation of poorly water soluble drug to 
polymeric micelles. The LC of polymeric micelles 
is influenced by several factors such as 
composition, molecular weight and structure of 
polymer and drug [24]. This result revealed that 
the chemical structure of drugs is the key factor 
to control EE and LC. It is thought that BSCS 
micellar encapsulation was occurred not only by 
hydrophobic interaction but also by the forces 
assembled via the attraction between benzyl 
groups in the copolymer and aromatic groups in 
drugs. These results were in agreement with 
previously studied encapsulation behaviors of 
anticancer drugs, octaethylporphine (OEP), 
meso-tetraphenyl porphine (mTPP) and 
camptothecin (CPT), in Pluronic and 
poly(ethyleneglycol)-distearoylphosphatidyl 
ethanolamine (PEG–DSPE) polymeric micelles. 
The results indicated that the high efficacy of 
drug loading depends on the type of polymer and 
drug used and their ratios. The phenyl groups in 
mTPP might lead to attraction between alkyl 
groups in the polymer and increase drug 
incorporation [25]. The particle sizes of the drugs 
encapsulated into polymeric micelles ranged 
from 312 to 433 nm and were larger than the 
blank polymeric micelles (226.63 nm) as a result 
of drug entrapment. The zeta potential of all 
micelles formation in deionized water (pH 5) 
exhibited negatively charge (-38 to -41 mV) of 
carboxyl group in hydrophilic moieties resulting in 




BSCS grafted copolymer has been successfully 
synthesized and prepared as polymeric micelles 
in aqueous solutions. NSAIDs (MX, PRX, KP and 
IND) have also been successfully incorporated in 
the hydrophobic inner core by evaporation 
method. Among the drug-loaded micelles, KP-
loaded BSCS polymeric micelles showed the 
highest loading capacity. Drug loading depends 
on the molecular structure of the drugs. 
Therefore, generation of BSCS polymeric micelle 
in this study represents an efficient and attractive 
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